Corrigendum for “Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib” [Acta Biomaterialia, 2023, 159, 237-246](S1742706123000569)(10.1016/j.actbio.2023.01.053)

It has come to our attention that some errors have been found in Figure 4e and Figure S11 in our original article. In Figure 4e, the image of H&E stained for AFG/SFB@PEG+L (row 1, column 6) and AFG+L (row 1, column 5) were mistakenly used, and the corrected version is shown below. In Figure S11, the image of H&E stained spleen for Control group (row 1, column 3) was mistakenly used, and the corrected version is shown below. The data analysis and conclusions remain unchanged in the paper. The authors apologize for any confusion or inconvenience caused.